Skip to main content
Caplight Logo









Lumoptik, Inc.

Lumoptik, Inc.

Private
Spring Grove, IllinoisHealthcare & Life Scienceshttps://www.brightpointmedical.com/

Last Round

Seed Round

Sep 18, 2026

Total Funding Raised

$1.65M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Lumoptik, Inc. is a medical device company that has developed the BrightPoint needle guidance system to assist physicians with needle placement during epidural and other surgical procedures.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales

AI Layer

Non-AI

Keywords

needle guidanceepidural guidancefiber optic sensormedical deviceloss of resistanceLORanesthesiology toolsorthopedic surgeryreal-time guidanceprocedural accuracyrazor and bladedisposable medical devicesmart needleoptical tissue sensingclinical workflow

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lumoptik, Inc. Comparables

Compare Lumoptik, Inc. with similar companies based on industry and business-model similarity.

Lumoptik, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
IntuiTap Medical, Inc.
86%
Ethos Medical
82%
Omeq Medical
82%

Lumoptik, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundSep 18, 2026
Corporate FundingOct 1, 2022

Key People

Founding team and executive leadership

Cole H.

Chief Executive Officer, Member Board of Directors

Executive Team

Lumoptik, Inc. Investors

Notable investors and investment history

Lumoptik, Inc. investors
InvestorRounds
TCA Venture GroupSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 18, 2026

    Raised $1.5M in Seed funding.

  • Jan 25, 2025

    Monthly visitors increased 800% MoM.

Lumoptik, Inc. Filings

Explore SEC and related filing metadata, where available.

Lumoptik, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Lumoptik, Inc.'s valuation, stock price, and market status.

Is Lumoptik, Inc. a public or private company?

Lumoptik, Inc. is a private company.

What is the current stock price of Lumoptik, Inc.?

Lumoptik, Inc. is a private company with no public stock price. Caplight tracks Lumoptik, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Lumoptik, Inc. worth (valuation)?

Valuation information for Lumoptik, Inc. is not publicly available.

Can I buy Lumoptik, Inc. stock?

Lumoptik, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Lumoptik, Inc.'s last funding round?

Lumoptik, Inc.'s most recent funding round was Corporate Funding on October 1, 2022.

Who are the main investors in Lumoptik, Inc.?

Key investors in Lumoptik, Inc. include TCA Venture Group.

Will Lumoptik, Inc. IPO soon?

No public IPO plans have been announced for Lumoptik, Inc..

How can I track Lumoptik, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lumoptik, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSpring Grove, Illinois
Employee Range3
Year FoundedN/A
Last FundingSep 18, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?